Funding
Amounts as reported; USD estimates shown only when they matchListed 2 funding records.
No chartable funding estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 3, 2026 | 亿元人民币 · Angel | 襄禾资本 | 1 source Source ↗ |
Evidence AIPher Raises RMB 100M in Angel RoundOn September 3, 2026, Beijing-based AIPher, an AI-native drug developer, raised RMB 100 million in an Angel round led by Xianghe Capital. Gao Bowen serves as CEO, Lan Yanyan as chief scientist and Zhang Yaqin as chief scientific advisor. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
| Jul 8, 2026 | Undisclosed · Equity | 华控技术转移有限公司 | No source link |
Evidence Aifeizhiyao raises an undisclosed amount in equity financingOn 2026-07-08, according to Xiniu Data, Aifeizhiyao completed equity financing for an undisclosed amount. Investors were Huakong Technology Zhuanyi Co., Ltd.. The company is an AI-native new drug developer. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 2 valuation records.
No chartable valuation estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 3, 2026 | — · Angel | 襄禾资本 | 1 source Source ↗ |
Evidence AIPher Raises RMB 100M in Angel RoundOn September 3, 2026, Beijing-based AIPher, an AI-native drug developer, raised RMB 100 million in an Angel round led by Xianghe Capital. Gao Bowen serves as CEO, Lan Yanyan as chief scientist and Zhang Yaqin as chief scientific advisor. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
| Jul 8, 2026 | — · Equity | 华控技术转移有限公司 | No source link |
Evidence Aifeizhiyao raises an undisclosed amount in equity financingOn 2026-07-08, according to Xiniu Data, Aifeizhiyao completed equity financing for an undisclosed amount. Investors were Huakong Technology Zhuanyi Co., Ltd.. The company is an AI-native new drug developer. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.